Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines?

Clerico A, Emdin M, Passino C.

Clin Chem Lab Med. 2014 Jul;52(7):959-63. doi: 10.1515/cclm-2013-0900.

PMID:
24501160
2.

Prognostic value of perioperative N-terminal pro-B-type natriuretic peptide in noncardiac surgery.

Borges FK, Furtado MV, Rossini AP, Bertoluci C, Gonzalez VL, Bertoldi EG, Grutcki DM, Rech LG, Magalhães M, Polanczyk CA.

Arq Bras Cardiol. 2013 Jun;100(6):561-70. doi: 10.5935/abc.20130090. Epub 2013 May 7. English, Portuguese.

3.

The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.

Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L, Schutt RC, Bolliger D, Cagini L, Cardinale D, Chong CP, Chu R, Cnotliwy M, Di Somma S, Fahrner R, Lim WK, Mahla E, Manikandan R, Puma F, Pyun WB, Radović M, Rajagopalan S, Suttie S, Vanniyasingam T, van Gaal WJ, Waliszek M, Devereaux PJ.

J Am Coll Cardiol. 2014 Jan 21;63(2):170-80. doi: 10.1016/j.jacc.2013.08.1630. Epub 2013 Sep 26. Review.

4.

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ.

J Am Coll Cardiol. 2009 Oct 20;54(17):1599-606. doi: 10.1016/j.jacc.2009.06.028. Review.

5.

Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery.

Farzi S, Stojakovic T, Marko T, Sankin C, Rehak P, Gumpert R, Baumann A, Höfler B, Metzler H, Mahla E.

Br J Anaesth. 2013 Apr;110(4):554-60. doi: 10.1093/bja/aes454. Epub 2012 Dec 17.

6.

Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.

Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D.

J Vasc Surg. 2009 Feb;49(2):435-41; discussion 441-2. doi: 10.1016/j.jvs.2008.08.063. Epub 2008 Nov 22.

7.

Prediction of early postoperative major cardiac events after elective orthopedic surgery: the role of B-type natriuretic peptide, the revised cardiac risk index, and ASA class.

Vetrugno L, Langiano N, Gisonni R, Rizzardo A, Venchiarutti PE, Divella M, Pompei L, Causero A, Rocca GD.

BMC Anesthesiol. 2014 Mar 21;14:20. doi: 10.1186/1471-2253-14-20.

8.

Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.

Yang JH, Choi JH, Ki YW, Kim DI, Kim DK, Park JR, Oh JK, Choi SH.

Korean J Intern Med. 2012 Sep;27(3):301-10. Epub 2012 Sep 1.

9.

Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery.

Mercantini P, Di Somma S, Magrini L, Kazemi Nava A, Scarinci A, La Torre M, Ferri M, Ferri E, Petrucciani N, Ziparo V.

World J Surg. 2012 Jan;36(1):24-30. doi: 10.1007/s00268-011-1354-6.

PMID:
22089921
10.

N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery.

Oscarsson A, Fredrikson M, Sörliden M, Anskär S, Eintrei C.

Br J Anaesth. 2009 Aug;103(2):206-12. doi: 10.1093/bja/aep139. Epub 2009 Jun 13.

11.

Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.

Ryding AD, Kumar S, Worthington AM, Burgess D.

Anesthesiology. 2009 Aug;111(2):311-9. doi: 10.1097/ALN.0b013e3181aaeb11. Review.

PMID:
19602961
12.

Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients.

Yun KH, Jeong MH, Oh SK, Choi JH, Rhee SJ, Park EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW.

Circ J. 2008 Feb;72(2):195-9.

13.

Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting.

Biccard BM, Devereaux PJ, Rodseth RN.

Anaesthesia. 2014 May;69(5):484-93. doi: 10.1111/anae.12635. Review.

14.

Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery.

Choi JH, Cho DK, Song YB, Hahn JY, Choi S, Gwon HC, Kim DK, Lee SH, Oh JK, Jeon ES.

Heart. 2010 Jan;96(1):56-62. doi: 10.1136/hrt.2009.181388. Epub 2009 Oct 26.

15.

Preoperative cardiovascular evaluation for noncardiac surgery.

Maddox TM.

Mt Sinai J Med. 2005 May;72(3):185-92. Review.

PMID:
15915313
16.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
17.

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Innovations (Phila). 2012 Jul-Aug;7(4):229-41. doi: 10.1097/IMI.0b013e3182747699.

PMID:
23123988
18.

N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.

Chong CP, Lim WK, Velkoska E, van Gaal WJ, Ryan JE, Savige J, Burrell LM.

Am J Cardiol. 2012 May 1;109(9):1365-73. doi: 10.1016/j.amjcard.2011.12.032. Epub 2012 Feb 28.

PMID:
22381157
19.

Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications.

Lurati Buse GA, Bolliger D, Seeberger E, Kasper J, Grapow M, Koller MT, Seeberger MD, Filipovic M.

Circulation. 2014 Sep 16;130(12):948-57. doi: 10.1161/CIRCULATIONAHA.113.007253. Epub 2014 Aug 6.

20.

Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery.

Schutt RC, Cevik C, Phy MP.

Am J Cardiol. 2009 Jul 1;104(1):137-40. doi: 10.1016/j.amjcard.2009.03.005. Epub 2009 May 13.

PMID:
19576335
Items per page

Supplemental Content

Write to the Help Desk